Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | ANPEP | P15144 | 2/20 | 0.47 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | ACP3 | P15309 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7372199 | 0.88 | PPARG (0.50) | CNR2TSHRKEAP1ANPEPERAP1 | |
| SCHEMBL3433828 | 0.88 | PPARG (0.50) | CNR2TSHRKEAP1ANPEPERAP1 | |
| SCHEMBL9753996 | 0.86 | CNR2 (0.47) | CNR2TSHRKEAP1ANPEPERAP1 | |
| SCHEMBL29223822 | 0.80 | TSHR (0.54) | CNR2TSHRMEN1KMT2ATDP1 | |
| P-Toluenesulfonamide SCHEMBL4747609 | 0.80 | ALDH1A1 (0.50) | TSHRALDH1A1 | |
| SCHEMBL12266041 | 0.78 | METAP2 (0.49) | CNR2TSHRANPEPERAP1KMT2A | |
| SCHEMBL11823662 | 0.77 | MMP12 (0.58) | TSHRHTTFFAR1 | |
| SCHEMBL4160692 | 0.77 | TSHR (0.47) | CNR2TSHRMEN1KMT2ANPC1 | |
| SCHEMBL6462807 | 0.76 | MMP12 (0.53) | CNR2TSHRKEAP1AKR1B1SMN1; SMN2 | |
| SCHEMBL27884209 | 0.76 | GRIK1 (0.54) | KEAP1KMT2ANPC1RAB9ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3903783-B1 | THERAPEUTIC AGENT FOR RNA VIRAL INFECTION OBTAINED BY COMBINING A PYRAZINE DERIVATIVE AND A COMPOUND INCREASING THE AMOUNT OF PYRAZINE DERIVATIVE RIBOSE TRIPHOSPHATE IN A CELL. | FUJIFILM TOYAMA CHEMICAL CO LTD (JP) | 2025-03-05 | — | — | EP | disclosed |
| CN-119213024-A | HMPV antibodies and uses thereof | 佐治亚大学研究基金会有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-117286113-A | Application of recombinant trypsin in influenza vaccine production of cell culture system without animal source component | 上海生物制品研究所有限责任公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-117222424-A | Alpha-1-antitrypsin (AAT) for the treatment and/or prophylaxis of neurological disorders | 阿格罗尼克斯股份有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-116782920-A | Neuropilin and angiotensin converting enzyme 2 fusion peptides for the treatment of viral infections | 常青树治疗公司 | 2023-09-19 | — | — | CN | disclosed |
| US-20230201238-A1 | THERAPEUTIC AGENT FOR AN RNA VIRUS INFECTION COMPRISING A COMBINATION OF A PYRAZINE DERIVATIVE AND A THIOPURINE DERIVATIVE | FUJIFILM TOYAMA CHEMICAL CO., LTD. (JP) | 2023-06-29 | — | — | US | disclosed |
| EP-4159215-A1 | THERAPEUTIC AGENT FOR RNA VIRAL INFECTION OBTAINED BY COMBINING PYRAZINE DERIVATIVE AND THIOPURINE DERIVATIVE | FUJIFILM Toyama Chemical Co., Ltd. (JP) | 2023-04-05 | — | — | EP | disclosed |
| US-20220096468-A1 | Therapeutic agent for RNA viral infection comprising a combination of pyrazine derivative and compound which increases amount of pyrazine derivative ribose triphosphate in cell | FUJIFILM TOYAMA CHEMICAL CO., LTD. (JP) | 2022-03-31 | — | — | US | disclosed |
| US-20180003712-A1 | KIT FOR DETECTING VIRUS | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2018-01-04 | — | — | US | disclosed |
| EP-3244211-A1 | KIT FOR DETECTING VIRUS | Huvet Bio, Inc. (KR) | 2017-11-15 | — | — | EP | disclosed |
| EP-3244210-A1 | KIT FOR DETECTING VIRUS | Huvet Bio, Inc. (KR) | 2017-11-15 | — | — | EP | disclosed |
| US-20170307612-A1 | KIT FOR DETECTING VIRUS | HUVET BIO, INC. (KR) | 2017-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220096468-A1 | Therapeutic agent for RNA viral infection comprising a combination of pyrazine derivative and compound which increases amount of pyrazine derivative ribose triphosphate in cell | EIF2AK2, NSUN2, ZC3HAV1 | CNR2 4236/4885TSHR 4231/4885KEAP1 1524/4885 |
| US-20230201238-A1 | THERAPEUTIC AGENT FOR AN RNA VIRUS INFECTION COMPRISING A COMBINATION OF A PYRAZINE DERIVATIVE AND A THIOPURINE DERIVATIVE | NSUN2, EIF2AK2, TPMT | CNR2 4055/4885TSHR 3361/4885KEAP1 2911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.